Does BPH Affect Ejaculation? Causes and Treatments

BPH, or benign prostatic hyperplasia, affects ejaculation in most men who have moderate-to-severe urinary symptoms from the condition. Roughly half of men presenting with lower urinary tract symptoms from BPH report some form of ejaculatory dysfunction, and the rate climbs steeply with symptom severity and age. What makes this particularly frustrating is that many of the treatments for BPH can also disrupt ejaculation, sometimes more than the disease itself. Understanding which problems come from the enlarged prostate, which come from the medications or surgery, and which newer options spare ejaculatory function gives you a much better shot at making an informed treatment decision.

How Common Ejaculatory Problems Are in Men with BPH

The numbers are higher than most men expect. In a large international study of men with lower urinary tract symptoms suggestive of BPH, decreased force of ejaculation was reported by about 78% and decreased semen volume by about 74%, making these the two most common complaints. The severity of urinary symptoms was the strongest predictor of ejaculatory trouble, and the bother these problems caused rose in lockstep: roughly 36% of men with mild urinary symptoms considered their ejaculatory dysfunction a problem, compared with about 64% of men with severe symptoms.¹ A comprehensive review found that about 46% of men presenting with urinary symptoms from BPH reported ejaculatory dysfunction overall, with the prevalence rising from roughly 30% in men aged 50–59 to about 74% in men aged 70–80.²

One finding that sometimes surprises clinicians is that while ejaculatory dysfunction becomes more common with age, the degree to which it bothers men does not track with age. The distress tracks with how bad the urinary symptoms are instead. A 55-year-old with severe urinary symptoms is likely to be just as bothered by ejaculatory changes as a 75-year-old with equally severe symptoms.²

Why BPH Itself Disrupts Ejaculation

Ejaculation is a two-phase process. During the first phase, called emission, the seminal vesicles, prostate, and vas deferens contract to push semen into the urethra. In the second phase, rhythmic contractions of pelvic muscles expel the semen outward while the bladder neck snaps shut to prevent semen from flowing backward into the bladder. Both phases rely on coordinated smooth-muscle contractions along a narrow anatomical corridor, and BPH disrupts that corridor in multiple ways.

As the prostate enlarges, it physically compresses the prostatic urethra and can distort the ejaculatory ducts that pass through the prostate gland. That compression alone can reduce the force and volume of the ejaculate. The bladder neck, which sits right at the junction where the prostate meets the bladder, can also be affected by the enlarged tissue, weakening its ability to seal shut during the expulsion phase. When the bladder neck doesn’t close properly, semen travels backward into the bladder instead of forward, a phenomenon called retrograde ejaculation. The enlarged prostate can also obstruct the outlet enough to impair the coordinated contractions needed for normal emission.

Beyond the mechanical squeeze, BPH is associated with chronic low-grade inflammation of the prostate. That inflammation can irritate the nerves and tissues involved in ejaculation, contributing to another symptom many men don’t connect to their prostate: painful ejaculation.

Painful Ejaculation and BPH

About one in five sexually active men with urinary symptoms suggestive of BPH report pain or discomfort during ejaculation. These men tend to have more severe urinary symptoms, greater overall bother, and higher rates of erectile dysfunction and reduced ejaculation compared with men who have urinary symptoms alone.³ The overlap with prostatitis-like symptoms suggests that inflammation in the prostate plays a significant role. Painful ejaculation is often undertreated because neither the patient nor the physician connects it to the prostate, yet addressing the underlying BPH and any concurrent inflammation can reduce or resolve it.

How BPH Medications Affect Ejaculation

If you’re taking medication for BPH, the pills themselves may be causing more ejaculatory disruption than the enlarged prostate. The two main drug classes used for BPH each interfere with ejaculation through different mechanisms.

Alpha-Blockers

Alpha-blockers like tamsulosin, silodosin, and alfuzosin relax the smooth muscle of the prostate and bladder neck to improve urine flow. The problem is that the same smooth-muscle relaxation also weakens the ejaculatory machinery. Alpha-blockers impair the contraction of the vas deferens, seminal vesicles, and prostate during the emission phase, and the relaxed bladder neck makes retrograde ejaculation more likely.⁴ Among the alpha-blockers, tamsulosin and silodosin are the most selective for the prostate but also the most likely to cause ejaculatory dysfunction, including markedly reduced semen volume or complete absence of ejaculation. One study of 111 patients on tamsulosin found ejaculatory disorders in about 65%.⁵

Alfuzosin tends to be somewhat gentler on ejaculation because it is less selective for the specific alpha-receptor subtypes that control the ejaculatory ducts. If ejaculatory function matters to you and your doctor recommends an alpha-blocker, the choice of which one can make a meaningful difference.

5-Alpha-Reductase Inhibitors and Combination Therapy

Finasteride and dutasteride work by shrinking the prostate over time. Their sexual side effects lean more toward reduced libido and erectile dysfunction, but ejaculatory disorders also occur, including decreased semen volume and orgasmic changes. When an alpha-blocker is combined with a 5-alpha-reductase inhibitor for synergistic relief of urinary symptoms, the risk of ejaculatory dysfunction climbs further. Reviews of combination therapy identify ejaculatory disorders, including complete absence of ejaculation, as the chief adverse effect.⁶

For many men, the trade-off is worthwhile because the urinary symptom relief is substantial. But no one should be surprised by ejaculatory changes on these medications, and the conversation about side effects should happen before the prescription is written, not after.

Traditional Surgery and Retrograde Ejaculation

Transurethral resection of the prostate, or TURP, has been the surgical gold standard for BPH for decades. It is highly effective at relieving obstruction. It is also notoriously hard on ejaculatory function. Standard TURP involves removing tissue from the prostate’s interior, and in the process, the bladder neck is typically disrupted. Without an intact bladder neck, semen flows backward into the bladder during orgasm instead of exiting through the penis. This retrograde ejaculation is painless and not medically dangerous, but it results in a “dry” orgasm. The sensation of orgasm is usually preserved, though many men describe it as diminished.

One modification that has shown some promise is performing TURP while deliberately preserving the bladder neck. Compared with standard TURP, this approach has been found to lower the rate of postoperative retrograde ejaculation while maintaining similar relief of urinary symptoms.⁷ The reduction in retrograde ejaculation remained stable through 12-month follow-up. Bladder-neck-sparing TURP is not universally offered, though, so if ejaculatory preservation is a priority, you need to ask your surgeon about their technique.

Newer Procedures That Spare Ejaculation

The growing recognition that men care about ejaculatory function has driven a wave of newer, less destructive surgical options. Three of the most discussed are the prostatic urethral lift, water vapor thermal therapy, and modified laser enucleation techniques.

Prostatic Urethral Lift

The prostatic urethral lift (marketed as UroLift) uses small implants to hold the enlarged prostate lobes apart, widening the urethral channel without cutting or removing any tissue. Because it avoids resection and specifically avoids injury to the bladder neck, ejaculatory ducts, and midline urethral structures, it has become the standout option for ejaculation preservation. In the multicenter BPH6 trial, the prostatic urethral lift group maintained a 100% ejaculatory function preservation rate at two years, compared with only 34% in the TURP group. Men who received the lift also showed improvement in ejaculatory function scores, whereas the TURP group experienced significant deterioration.⁸ European urology guidelines now strongly recommend this procedure for men with lower urinary tract symptoms who want to preserve ejaculatory function, provided the prostate is under a certain size and has no obstructive middle lobe.⁹

The trade-off is that the urethral lift produces more modest urinary symptom improvement than TURP and may not be suitable for very large prostates or those with a prominent middle lobe. It is best suited for men with moderate symptoms who rank ejaculatory preservation highly.

Water Vapor Thermal Therapy

Rezūm uses targeted bursts of steam to destroy excess prostate tissue. It is performed as an outpatient procedure, typically under local anesthesia, and the dead tissue is gradually reabsorbed by the body. A systematic review and meta-analysis found that ejaculatory distress scores improved significantly from one month through 12 months after the procedure, while overall ejaculatory function scores remained largely stable over time.¹⁰ An updated systematic review across a range of prostate sizes confirmed that ejaculatory function was preserved in the majority of patients, in contrast to the high dysfunction rates seen with resective procedures.¹¹

Rezūm can handle a wider range of prostate sizes than the urethral lift, including prostates with a middle lobe. Recovery involves a temporary catheter for several days and a waiting period of weeks before full symptom improvement. For men who want tissue reduction without the ejaculatory cost of TURP, Rezūm occupies a useful middle ground.

Ejaculation-Sparing Laser Enucleation

Holmium laser enucleation of the prostate (HoLEP) is a powerful technique for large prostates. Standard HoLEP enucleates the entire interior of the prostate, which gives excellent long-term urinary relief but historically comes with high rates of retrograde ejaculation, much like TURP. In recent years, surgeons have developed modified HoLEP techniques that deliberately preserve key structures: the tissue around the verumontanum (a small mound on the urethral floor that houses the ejaculatory duct openings), the anterior urethral mucosa, and the bladder neck fibers. A systematic review found that these preservation approaches achieved antegrade ejaculation rates of 70–85% in selected patients, a dramatic improvement over standard HoLEP.¹² A randomized trial comparing ejaculation-preserving HoLEP to standard HoLEP confirmed that the modified technique improved both early continence recovery and ejaculation preservation.¹³

Similar ejaculation-sparing modifications have been developed for GreenLight laser procedures. In one comparative study, the ejaculation-sparing technique yielded antegrade ejaculation in about 60% of patients at six months, versus roughly 13% with the standard approach. The ejaculation-sparing technique was a strong predictor of maintaining antegrade ejaculation after surgery.¹⁴ These are still relatively new techniques, and not all surgeons are trained in them, but the results are encouraging enough that it is worth asking about them if you are considering laser surgery for a large prostate.

Prostatic Artery Embolization

Prostatic artery embolization (PAE) is a nonsurgical option performed by an interventional radiologist. Tiny particles are injected into the arteries feeding the prostate, cutting off blood supply and causing the prostate to shrink over weeks. Because it doesn’t involve cutting through the urethra or bladder neck, you might expect it to be gentle on ejaculation. The reality is mixed. A reassessment of two prospective clinical trials found ejaculatory disorders in about 56% of patients after PAE: roughly 40% experienced diminished ejaculation, and about 16% developed complete absence of ejaculation. The researchers attributed these changes to degenerative damage to the ejaculatory structures from interrupted blood supply.¹⁵

A separate retrospective study reported a lower rate, with about 10% of patients developing ejaculatory dysfunction, though the authors cautioned that the small sample size limited confidence in that figure.¹⁶ The wide range between studies (10% to 56%) reflects differences in how ejaculatory dysfunction was measured and the populations studied. PAE is not the ejaculation-preserving slam dunk it is sometimes marketed as, and men considering it should discuss these uncertainties with their radiologist.

How Ejaculatory Dysfunction Is Measured

You might wonder how researchers actually quantify something as subjective as ejaculatory function. The main tool is the Male Sexual Health Questionnaire for Ejaculatory Dysfunction (MSHQ-EjD), a validated short questionnaire that asks about ejaculatory force, volume, frequency, and how much the changes bother you. It was developed and validated across large populations of men with BPH-related urinary symptoms, and the ejaculatory force and volume items are the most sensitive markers for distinguishing men with mild versus moderate-to-severe urinary symptoms.¹⁷ When you see clinical trials reporting on ejaculatory outcomes after BPH treatment, they are almost always using this instrument or a close variant.

Knowing this tool exists is useful beyond the research context. If your doctor has never asked you about ejaculatory function, bringing it up yourself and mentioning the MSHQ-EjD can help steer the conversation toward measurable outcomes. Many men are reluctant to raise the topic, and many physicians do not routinely ask about it, even though ejaculatory dysfunction is one of the most common consequences of BPH and its treatment.

The Link Between BPH, Urinary Symptoms, and Semen Quality

For men who are still interested in fertility, there is an additional wrinkle. The urinary obstruction and prostate enlargement associated with BPH do not just change how ejaculation feels; they may change what comes out. A study of middle-aged men found that total sperm count and sperm density decreased as urinary symptom severity and total prostate volume increased. Lower urinary tract symptoms, prostate enlargement, and bladder outlet obstruction were all negatively correlated with main semen parameters.¹⁸ While most men diagnosed with BPH are past their reproductive years, a growing number of men in their late 40s and 50s are seeking to father children, and this finding is worth knowing if that applies to you.

Psychological and Quality-of-Life Effects

Ejaculatory dysfunction from BPH doesn’t exist in a vacuum. It overlaps with erectile difficulties, urinary bother, and the broader psychological toll of a condition that affects some of the most private aspects of daily life. Research has found that the severity of urinary symptoms has a direct adverse impact on both sexual function and mental health, and that improving prostate and lower urinary tract health positively affects psychological well-being.¹⁹ The clinical association between BPH-related urinary symptoms and sexual dysfunction is well established, and urologists increasingly treat both as intertwined rather than as separate problems.²⁰

This has practical implications for treatment decisions. If you are choosing between therapies based solely on how well they relieve urinary symptoms, you may be overlooking the fact that a treatment that worsens ejaculatory function could leave you psychologically worse off even as your urine stream improves. Thinking about the full picture from the start, not just the prostate symptoms in isolation, tends to produce better long-term satisfaction with whatever path you choose.

When to Prioritize Ejaculatory Preservation

Not every man with BPH needs to weigh ejaculatory preservation equally. For some men, dry orgasm is a minor inconvenience compared with the relief of finally being able to empty their bladder. For others, especially younger men or those in active sexual relationships, losing normal ejaculation is a deal-breaker that colors every aspect of their well-being. There is no universal right answer, but there are a few situations where the question deserves extra attention:

Active fertility goals: If you want to father children, any treatment that causes retrograde ejaculation or anejaculation will make natural conception impossible. This alone can shift the calculus toward ejaculation-sparing options.
Moderate symptoms: Men with moderate urinary bother who are otherwise managing well may find that an ejaculation-sparing procedure like the prostatic urethral lift or Rezūm gives them enough symptom relief without the sexual trade-offs of TURP.
Medication-induced changes: If your ejaculatory dysfunction started or worsened after beginning an alpha-blocker, talk to your doctor about switching to a different agent or adjusting the dose. Ejaculatory side effects from medications are usually reversible once the drug is stopped.
Large prostates needing surgery: If your prostate is large enough to require enucleation, ask specifically about ejaculation-sparing HoLEP or GreenLight techniques. Not all surgeons offer them, but they exist and the outcomes are measurably better for ejaculatory preservation.

The most important step, and the one most often skipped, is making sure your doctor knows that ejaculatory function matters to you before a treatment plan is locked in. Research on patient perspectives consistently points to a gap between what men care about and what physicians routinely discuss. If the topic is not raised, the default is often whatever treats the urinary symptoms most effectively, regardless of sexual consequences.